Jay H. Traverse

12.2k total citations · 2 hit papers
136 papers, 5.9k citations indexed

About

Jay H. Traverse is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jay H. Traverse has authored 136 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 57 papers in Surgery and 33 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jay H. Traverse's work include Cardiac Imaging and Diagnostics (33 papers), Mesenchymal stem cell research (27 papers) and Acute Myocardial Infarction Research (25 papers). Jay H. Traverse is often cited by papers focused on Cardiac Imaging and Diagnostics (33 papers), Mesenchymal stem cell research (27 papers) and Acute Myocardial Infarction Research (25 papers). Jay H. Traverse collaborates with scholars based in United States, Canada and Poland. Jay H. Traverse's co-authors include Timothy D. Henry, Gary L. Schaer, Robert J. Bache, Iacopo Olivotto, Susan A. Casey, Franco Cecchi, Alberto Dolara, Barry J. Maron, Nabil Dib and Anthony N. DeMaria and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Jay H. Traverse

129 papers receiving 5.7k citations

Hit Papers

A Randomized, Double-Blind, Placebo-Controlled, Dose-Esca... 2001 2026 2009 2017 2009 2001 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
    2009 989 citations Joshua M. Hare, Jay H. Traverse et al. Journal of the American College of Cardiology profile →
  2. Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
    2001 563 citations Jay H. Traverse et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay H. Traverse United States 36 2.8k 2.5k 1.6k 1.5k 890 136 5.9k
Shmuel Fuchs Israel 33 2.6k 0.9× 2.4k 1.0× 1.4k 0.9× 1.4k 1.0× 658 0.7× 110 5.7k
Albrecht Elsässer Germany 32 2.3k 0.8× 3.0k 1.2× 1.9k 1.2× 1.1k 0.7× 560 0.6× 170 5.9k
Gary L. Schaer United States 32 2.0k 0.7× 2.1k 0.8× 1.1k 0.7× 884 0.6× 576 0.6× 80 5.1k
Christof Stamm Germany 39 3.2k 1.1× 1.7k 0.7× 1.6k 1.0× 1.6k 1.1× 1.2k 1.3× 151 5.8k
Mariann Gyöngyösi Austria 38 1.8k 0.7× 2.1k 0.8× 1.7k 1.1× 639 0.4× 456 0.5× 178 4.9k
Bodo E. Strauer Germany 32 2.6k 0.9× 2.8k 1.1× 1.4k 0.9× 1.9k 1.3× 883 1.0× 129 6.3k
Toshiji Iwasaka Japan 49 2.4k 0.9× 4.3k 1.7× 3.8k 2.4× 1.6k 1.1× 458 0.5× 303 9.8k
Martina Britten Germany 16 3.2k 1.1× 2.5k 1.0× 2.7k 1.7× 2.3k 1.5× 1.1k 1.2× 21 7.4k
Roger J. Laham United States 38 2.3k 0.8× 1.8k 0.7× 2.4k 1.5× 338 0.2× 667 0.7× 150 5.5k
Florian Seeger Germany 33 1.7k 0.6× 860 0.3× 2.0k 1.3× 1.3k 0.9× 394 0.4× 79 4.6k

Countries citing papers authored by Jay H. Traverse

Since Specialization
Citations

This map shows the geographic impact of Jay H. Traverse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay H. Traverse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay H. Traverse more than expected).

Fields of papers citing papers by Jay H. Traverse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay H. Traverse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay H. Traverse. The network helps show where Jay H. Traverse may publish in the future.

Co-authorship network of co-authors of Jay H. Traverse

This figure shows the co-authorship network connecting the top 25 collaborators of Jay H. Traverse. A scholar is included among the top collaborators of Jay H. Traverse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay H. Traverse. Jay H. Traverse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ducrocq, Grégory, Marnie Bertolet, John H. Alexander, et al.. (2025). Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. American Heart Journal. 282. 146–155. 2 indexed citations
2.
3.
Povsic, Thomas J., Timothy D. Henry, Jay H. Traverse, et al.. (2023). EXACT Trial: Results of the Phase 1 Dose-Escalation Study. Circulation Cardiovascular Interventions. 16(8). e012997–e012997. 4 indexed citations
4.
Simsek, Bahadir, Spyridon Kostantinis, Judit Karácsonyi, et al.. (2022). Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS‐BIFURCATION registry. Catheterization and Cardiovascular Interventions. 100(5). 749–755. 5 indexed citations
5.
Simsek, Bahadir, Spyridon Kostantinis, Judit Karácsonyi, et al.. (2022). Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS‐BIFURCATION registry. Catheterization and Cardiovascular Interventions. 99(4). 1038–1044. 3 indexed citations
6.
Wang, Xiaoyin, Ronak Derakhshandeh, Dmitry Kostyushev, et al.. (2020). Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials. PLoS ONE. 15(8). e0237401–e0237401. 2 indexed citations
7.
Makkar, Raj, Dean J. Kereiakes, Frank Aguirre, et al.. (2020). Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. European Heart Journal. 41(36). 3451–3458. 87 indexed citations
8.
García, Santiago, Christian Schmidt, Ross Garberich, et al.. (2020). Temporal changes in patient characteristics and outcomes in ST‐segment elevation myocardial infarction 2003–2018. Catheterization and Cardiovascular Interventions. 97(6). 1109–1117. 18 indexed citations
9.
Megaly, Michael, Iosif Xenogiannis, Evangelia Vemmou, et al.. (2020). Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis. Catheterization and Cardiovascular Interventions. 97(1). 32–38. 18 indexed citations
10.
Harris, Kevin M., Ross Garberich, Jay H. Traverse, et al.. (2020). CARDIOLOGY RESEARCH INTERNSHIP FOR UNDERGRADUATE STUDENTS PROVIDES UNIQUE OPPORTUNITY FOR NEXT GENERATION OF HEALTH CARE PROFESSIONALS. Journal of the American College of Cardiology. 75(11). 3655–3655. 1 indexed citations
11.
Omer, Mohamed, Ross Garberich, Scott W. Sharkey, et al.. (2020). CLINICAL CHARACTERISTICS AND OUTCOMES OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH CARDIOGENIC SHOCK AND CARDIAC ARREST. Journal of the American College of Cardiology. 75(11). 118–118. 4 indexed citations
12.
Lobo, Angie S., Yader Sandoval, M. Nicholas Burke, et al.. (2019). Sleep Deprivation in Cardiology: A Multidisciplinary Survey. ˜The œJournal of invasive cardiology. 31(6). 195–198. 1 indexed citations
13.
García, Santiago, Christian Schmidt, Ross Garberich, et al.. (2019). TCT-509 Trends in the Management of ST-Segment Elevation Myocardial Infarction (STEMI): Insights From a Regional STEMI Program (2003 to 2018). Journal of the American College of Cardiology. 74(13). B504–B504. 1 indexed citations
14.
Tajti, Péter, Yader Sandoval, Larissa Stanberry, et al.. (2018). Incidence, predictors, management and outcomes of coronary perforations. Catheterization and Cardiovascular Interventions. 93(1). 48–56. 35 indexed citations
15.
Stanberry, Larissa, Ross Garberich, Yader Sandoval, et al.. (2018). Impact of sleep deprivation on the outcomes of percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 92(6). 1118–1125. 1 indexed citations
16.
Lobo, Angie S., Yader Sandoval, M. Nicholas Burke, et al.. (2018). SLEEP DEPRIVATION IN CARDIOLOGY: A MULTIDISCIPLINARY SURVEY. Journal of the American College of Cardiology. 71(11). A2632–A2632. 1 indexed citations
17.
Makkar, Raj, Richard A. Schatz, Jay H. Traverse, et al.. (2014). TCT-152 ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration (ALLSTAR): The Six Month Phase I Safety Results. Journal of the American College of Cardiology. 64(11). B46–B46. 4 indexed citations
18.
Hare, Joshua M., Jay H. Traverse, Timothy D. Henry, et al.. (2009). A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction. Journal of the American College of Cardiology. 54(24). 2277–2286. 989 indexed citations breakdown →
19.
Traverse, Jay H., et al.. (2007). Effect of K + ATP Channel and Adenosine Receptor Blockade During Rest and Exercise in Congestive Heart Failure. Circulation Research. 100(11). 1643–1649. 12 indexed citations
20.
Traverse, Jay H., Yale L. Wang, Ivan Chavez, et al.. (2006). Abstract 1747: Post-Conditioning Reduces Infarct Size and Improves LV function During Acute Myocardial Infarction. Circulation. 114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shmuel Fuchs Breakdown of academic impact, for papers by Albrecht Elsässer Breakdown of academic impact, for papers by Gary L. Schaer Breakdown of academic impact, for papers by Christof Stamm Breakdown of academic impact, for papers by Mariann Gyöngyösi Breakdown of academic impact, for papers by Bodo E. Strauer Breakdown of academic impact, for papers by Toshiji Iwasaka Breakdown of academic impact, for papers by Martina Britten Breakdown of academic impact, for papers by Roger J. Laham Breakdown of academic impact, for papers by Florian Seeger
Rankless by CCL
2026